MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517097009 A) filed by Affirma Biotech S. L., Barcelona, Spain, on Oct. 8, for 'novel pd-l1 inhibitors.'
Inventor(s) include Berges Fraile, Isabel; Almansa Rosales, Carmen; and Basu, Sujay.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds for modulating PD-1/PD-L1 protein/protein interaction that are useful in the treatment of various diseases associated with over-expression of PD-1/PD-L1, including infectious diseases and cancer. The invention additionally relates to compositions comprising such compounds as well as to their uses."
The patent application was internationally filed on Mar. 22, 2024, under International application No.PCT/EP2024/057862.
Disclaimer: Curated by HT Syndication.
